FILI-PHARMA
ActiveSummary
FILI-PHARMA has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €968,090 and a net result of €140,905. Equity has been growing by about 13% per year since 2019. Its solvency ranks better than 84% of 1,139 sector peers (NACE 77, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 27-01-2010 Normal situation
- Activity
- Rental and leasing activities NACE 77225and 5 others
- Establishment unit
- 2.185.308.446 9406 Ninove, since 21-01-2010
- Financial year end
- 30 June
- Peppol
- Reachable since 23-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €102,643
- ▲ 1.4%
- Turnover
- ≈ €260,000
- estimated
- Profit
- €140,905
- ▼ 16.3%
- Equity
- €968,090
- ▲ 17.0%
- Total assets
- €1.2m
- ▲ 11.1%
Score breakdownlowers riskSize: total assets €1.2mLiquidity: current ratio 1.59, cash €339,641Equity €968,090 (78.0% of total assets)Founded in 2010Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 77, micro). It does better than 92% of them on solvency, 85% on liquidity, 78% on profitability and 70% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 2 days before the deadline. In the sector (NACE 77), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Change of role: VAN der ELST Filip Roger Jozef, from manager to director
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as FILI-PHARMA: rental and leasing activities (NACE 77225). They are comparable in size and age: total assets between €501,000 and €2.6m, founded between 2005 and 2014.
| Company | Total assets | Gross margin |
|---|---|---|
| FILI-PHARMA Ninove | €1.2m | €0.1m |
| LABORATOIRE CARDIO CONTACT BENELUX Ukkel | €1.0m | €0.1m |
| VIVAMUT Verviers | €0.8m | €0.2m |
| NORD EXPLOITATION OPHTALMOLOGIQUE Etterbeek | €2.6m | €0.1m |
| INFIMED BENELUX Tournai | €1.0m | €0.2m |
| ODEMEDICA Genappe | €0.6m | €0.2m |
| PORTYVIT Braine-l'Alleud | €0.5m | €0.06m |
Key facts about FILI-PHARMA
- What is the company number of FILI-PHARMA?
- The company number of FILI-PHARMA is 0822.645.914. The VAT number is the same number with BE in front: BE 0822.645.914.
- Where is FILI-PHARMA based?
- The registered office is at Smid Lambrechtstraat 70, 9406 Ninove.Company details
- What does FILI-PHARMA do?
- According to the KBO register, the main activity is rental and leasing activities (NACE 77225).
- What is the legal form of FILI-PHARMA?
- The legal form of FILI-PHARMA is Private limited company (BV).
- When was FILI-PHARMA founded?
- FILI-PHARMA was founded on 27-01-2010.
- Is FILI-PHARMA still active?
- Yes, FILI-PHARMA is an active enterprise in the KBO register.
- What is the turnover of FILI-PHARMA?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €102,643 and 1,647 comparable companies of the same size. It probably lies between €160,000 and €490,000. It is a rough estimate.Financials
- Is FILI-PHARMA profitable?
- In financial year 2025, FILI-PHARMA made a profit of €140,905.
- Where can I find the annual accounts of FILI-PHARMA?
- FILI-PHARMA filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FILI-PHARMA due?
- FILI-PHARMA must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.